Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Nov 2017 for Allena Pharmaceuticals, Inc..
Filing timeline
BuySaleHBM BioCapital II LP
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
HBM BioCapital II LP: trading record in brief
This profile gathers the share dealings of HBM BioCapital II LP in Allena Pharmaceuticals, Inc. Activity is concentrated on a single trading day, 6 November 2017, with 3 filings.
No open-market sale appears; the market trades are 1 purchase worth €861k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 8 November 2017, reports a transaction in Allena Pharmaceuticals, Inc. The most recent open-market purchase was published on 8 November 2017, 3,271 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to HBM BioCapital II LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
1,426,061 sharesCommon StockSEC:0001179110-17-013895:0
140,841 sharesCommon StockSEC:0001179110-17-013895:1
71,428 shares@ US$14.00100.0% of flowCommon StockSEC:0001179110-17-013895:2
Canonical exit: 4 Feb 2018 (T+90)
3 of 3 declarations
